Katoh S, Ida K, Mizunoya A
Department of Internal Medicine, Murakami Memorial Hospital, Asahi University, Gifu City, Japan.
Int J Artif Organs. 1991 Mar;14(3):136-40.
We screened 89 patients undergoing chronic hemodialysis for irregular isoantibodies. Irregular isoantibodies were detected in six patients (6.7%). This is an extremely high percentage compared with previous reports, considering that the presence of irregular isoantibodies was estimated to be 2.91% in multiparas, in whom they were found most frequently. This may be due to the fact that hemodialysis patients often receive blood transfusions but it also suggests that hemodialysis per se may induce the production of irregular isoantibodies. The blood-group specificities of the irregular isoantibodies detected were anti-N, anti-Leb + anti-HI, anti-Lea + anti-Leb, anti-H and anti-I, anti-P1, anti-rh" (E). The majority of the cases with irregular isoantibodies were examined because of clinical problems during hemodialysis. Therefore, we checked for the presence of irregular isoantibodies before the induction of hemodialysis and every three to six months thereafter.
我们对89例接受慢性血液透析的患者进行了不规则同种抗体筛查。6例患者(6.7%)检测到不规则同种抗体。与之前的报告相比,这一比例极高,因为据估计,多产妇中不规则同种抗体的存在率为2.91%,而多产妇是不规则同种抗体最常出现的人群。这可能是由于血液透析患者经常接受输血,但这也表明血液透析本身可能会诱导不规则同种抗体的产生。检测到的不规则同种抗体的血型特异性为抗N、抗Leb + 抗HI、抗Lea + 抗Leb、抗H和抗I、抗P1、抗rh"(E)。大多数检测到不规则同种抗体的病例是由于血液透析期间的临床问题而接受检查的。因此,我们在开始血液透析前以及此后每三到六个月检查一次是否存在不规则同种抗体。